Inhalation Sciences receives new order worth 53,000 Euro from returning customer
Inhalation Sciences AB (ISAB) has received a new order worth 53,000 Euro from a regular client – a large global player in the field of inhaled therapies with a strong development pipeline based in Europe. The order is for additional modules and accessories that will expand the client’s two existing PreciseInhale systems.The client is a loyal ISAB customer, with two PreciseInhale systems in place. The client’s team carry out advanced in vivo work on New Chemical Entities, using the highly accurate preclinical data generated by PreciseInhale to significantly reduce risk in the later clinical